A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);细胞增殖(Cell Proliferation);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);人类(Humans);吲哚类(Indoles);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);模型, 分子(Models, Molecular);分子结构(Molecular Structure);蛋白激酶抑制剂(Protein Kinase Inhibitors);构效关系(Structure-Activity Relationship);肿瘤细胞, 培养的(Tumor Cells, Cultured);fms样酪氨酸激酶3(fms-Like Tyrosine Kinase 3)
DOI
10.1016/j.ejmech.2020.112232
PMID
32199135
发布时间
2020-11-30
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文